Gene therapy shows promise for treating Niemann-Pick disease type C1
Por um escritor misterioso
Descrição
NIH researchers demonstrated that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1.
mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient Fibroblasts
Models to study basic and applied aspects of lysosomal storage disorders - ScienceDirect
mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient Fibroblasts
Drug Delivery System for Niemann Pick Type C1 Disease Discovered
Reality of Rare Diseases: A Unique Perspective About Rare Diseases
The complexity of a monogenic neurodegenerative disease: More than two decades of therapeutic driven research into Niemann-Pick type C disease - ScienceDirect
IJMS, Free Full-Text
Niemann-Pick disease type C, Orphanet Journal of Rare Diseases
PPT - Niemann -Pick Disease PowerPoint Presentation, free download - ID:2977714
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS - The Lancet Child & Adolescent Health
Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia: Molecular Therapy - Methods & Clinical Development
delta – Columbus Children's Foundation
PDF) Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
Like a tunnel for cholesterol': Scientists show how 'bad' cholesterol gets into cells
Niemann-Pick Disease, Type C: Diagnosis, Management and Disease-Targeted Therapies in Development - ScienceDirect